OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
Bin Yang, Jing Gao, Qing Pei, et al.
Advanced Science (2020) Vol. 7, Iss. 23
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy
Bin Ji, Minjie Wei, Bin Yang
Theranostics (2021) Vol. 12, Iss. 1, pp. 434-458
Open Access | Times Cited: 321

Acidity‐Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer
Rundi Song, Tianliang Li, Jiayi Ye, et al.
Advanced Materials (2021) Vol. 33, Iss. 31
Closed Access | Times Cited: 236

Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy
Lili Cheng, Xiaoge Zhang, Junjie Tang, et al.
Biomaterials (2021) Vol. 275, pp. 120964-120964
Closed Access | Times Cited: 232

Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Cheng‐Liang Kuo, Ananth Ponneri Babuharisankar, Ying‐Chen Lin, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 176

Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
Nada S. Aboelella, Caitlin Brandle, Timothy Kim, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 986-986
Open Access | Times Cited: 156

A “Closed‐Loop” Therapeutic Strategy Based on Mutually Reinforced Ferroptosis and Immunotherapy
Yaqian Du, Rui Zhang, Jiani Yang, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 13
Closed Access | Times Cited: 140

Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
Yanhui Zheng, Yaobao Han, Qiao Sun, et al.
Exploration (2022) Vol. 2, Iss. 3
Open Access | Times Cited: 118

Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery
Man Kyu Shim, Suah Yang, In‐Cheol Sun, et al.
Advanced Drug Delivery Reviews (2022) Vol. 183, pp. 114177-114177
Closed Access | Times Cited: 115

Smart drug delivery systems for precise cancer therapy
Xiaoyou Wang, Chong Li, Yiguang Wang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4098-4121
Open Access | Times Cited: 115

Nanoparticle-based medicines in clinical cancer therapy
Shuhang Wang, Keman Cheng, Kun Chen, et al.
Nano Today (2022) Vol. 45, pp. 101512-101512
Closed Access | Times Cited: 111

Stimulus-responsive self-assembled prodrugs in cancer therapy
Xiao Dong, Rajeev Kungur Brahma, Chao Fang, et al.
Chemical Science (2022) Vol. 13, Iss. 15, pp. 4239-4269
Open Access | Times Cited: 84

Responsive biomaterials: optimizing control of cancer immunotherapy
Lulu Xue, Ajay S. Thatte, David Mai, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 2, pp. 100-118
Closed Access | Times Cited: 52

Photothermal “nano-dot” reactivate “immune-hot” for tumor treatment via reprogramming cancer cells metabolism
Lu Yang, Yang Wang, Weijian Liu, et al.
Biomaterials (2023) Vol. 296, pp. 122089-122089
Closed Access | Times Cited: 50

Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
Mehregan Babamohamadi, Nastaran Keshavarz Mohammadi, Elham Faryadi, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 31

Mitochondrial Localized In Situ Self‐Assembly Reprogramming Tumor Immune and Metabolic Microenvironment for Enhanced Cancer Therapy
Zhilong Wang, Qian Wang, Hongmei Cao, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 26

MXene‐Integrated Composites for Biomedical Applications: Synthesis, Cancer Diagnosis, and Emerging Frontiers
A. K. Saxena, Aman Tyagi, Sushipra Vats, et al.
Small Science (2025)
Open Access | Times Cited: 2

Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate
Lu Yang, Feng Xu, Yang Wang, et al.
Biomaterials (2021) Vol. 278, pp. 121167-121167
Closed Access | Times Cited: 94

Plasmon‐Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway
Yuan Ding, Zhongquan Sun, Yong Gao, et al.
Advanced Materials (2021) Vol. 33, Iss. 34
Closed Access | Times Cited: 88

The Development of Chiral Nanoparticles to Target NK Cells and CD8+ T Cells for Cancer Immunotherapy
Weiwei Wang, Jing Zhao, Changlong Hao, et al.
Advanced Materials (2022) Vol. 34, Iss. 16
Closed Access | Times Cited: 69

Multifunctional Au Modified Ti3C2-MXene for Photothermal/Enzyme Dynamic/Immune Synergistic Therapy
Xin Chang, Qiong Wu, Yuanyu Wu, et al.
Nano Letters (2022) Vol. 22, Iss. 20, pp. 8321-8330
Closed Access | Times Cited: 63

RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy
Ying Hao, Yuwen Chen, Xinlong He, et al.
Biomaterials (2022) Vol. 293, pp. 121975-121975
Closed Access | Times Cited: 60

Indocyanine green potentiated paclitaxel nanoprodrugs for imaging and chemotherapy
Xiujuan Xiang, Xuan Feng, Shaojin Lu, et al.
Exploration (2022) Vol. 2, Iss. 4
Open Access | Times Cited: 55

Molecular polymer bottlebrushes in nanomedicine: therapeutic and diagnostic applications
Markus Müllner
Chemical Communications (2022) Vol. 58, Iss. 38, pp. 5683-5716
Closed Access | Times Cited: 42

Chemically engineering cells for precision medicine
Yixin Wang, Zhaoting Li, Fanyi Mo, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 3, pp. 1068-1102
Closed Access | Times Cited: 41

Page 1 - Next Page

Scroll to top